Member Info for Aberdeenman

Wress This is definately setup for a meduim term exit Prospectus spells it out. Either a defensive buyout by a large pharma to protect their existing market share to prevent these first to market generics or from a competitor to said large pharma. My finger in the air guess is around £400m but could be way higher given they quote the sale of Anacor ($5.2B) as analogous

Lol I have a chunk but nowhere near enough. Got another 75-100k ready to buy more from the off That brings me to another point, some here will have been watching/buying on the morning of suspension, I was and trying to get more. The MM's had almost zero stock. So when this opens next month that situation will be unchanged. About 90% of the enlarged share capital will be closely held, so until some people sell they will have nothing, ergo the price rises sharply, as people like me try to buy more. All in all looks very very good, albeit I will have to pay a premuim for more :-(

No worries Eddie, good luck wherever you decide to put your cash. Agree Wress, Winnifrith and the fraudsters at Shitprophets are just bitter. They don't bother attacking companies that they extort money, placing shares or exhibition attendance money from. Winnifrith has also lost PI's millions of pounds from his failed investment fund, and the embezzled monies from that fund have never turned up!, why anyone listens to him is beyond me. Anyone wanting further reading on The embezzled funds that winnifrith was involved with, link below https://goo.gl/HKw4KU

Think you may have the wrong Board Eddie. This has been suspended for a year, was not dropping before suspension, and as the deal just published is very attractive is unlikely to drop any time soon. Added to that it will not be trading till 16th October. Good luck with your 5k, there are some great opportunities out there at the moment, including here, from next month. I think, however, it may be difficult to get hold of any decent amount of shares. Major shareholders have locked themselves in for 18 months, and free float is likely to be only around 10% of enlarged share capital This is likely to be a major earner for those willing to hold

Cannot argue with you there itsgambling!

Lol Wres, Not saying it will definitely do 100 bags, but one thing is certain, it is going to make us a lot of money. Don't think I have ever seen major shareholders like Spreadex lock themselves in for 18 months......

This is going to be one hell of an interesting journey!! Great reading in the admission document. They will have £2m cash to get NPX001 and NPX002 to a stage where they can license, indeed they expect licensing deal within a few weeks to a few months. These deals will be for multi £m, and they also have around £7.5m to come from options and CLN, that will add a lot to their war chest. They are also expecting to add 5-15 additional patents, and develop other areas where cocrystals can transform treatment. NPX001's target Oncology treatment is already available globally from one global pharmaceutical company, the new cocrystal method deployed by Nuformix will enable the first generic competitor to this company and treatment. That can mean a couple of things: The existing company will desperately strangle Nuformix to protect profit by buying the rights, or just buying the company, or; Another large pharmaceutical company will acquire the license to produce the therapy. Win win for Nuformix and us. They are fully expecting a trade sale within a couple of years, with all the major shareholders locked in for 18 months. Million dollar question is, what will the exit look like here??? The have quoted the sale of Anacor to Pfizer ($5.2B) as analogous, albeit Anacor was further down the line. I am going to hazard a guess at a minimum of £500m but could be in the £B's That puts the potential at somewhere between 25 bags and around 100 bags from the 4p placing price, over the course of about 2 years. This company is doing things on a Global stage, it uses the word 'disrupting' when talking about existing multi multi $B treatments. One thing Pharma doesn't like is their profitable treatments being disrupted, this will get taken out, and for a very high price. The scientists and Advisors are world class, they are ahead of all competition (at present), these share are going to be worth an awful lot of money. I shall be holding onto mine, I can wait a couple of years, £40k into between £1m and £4m in two years, yes please. Standard list, not your usual AIM crap. I can see strong demand for this and an early push north, then shortly afterwards when the licensing deals start to roll in......

Proxy form should come through your broker. If your shares are in a nominee account, the default is to pass resolutions unless you tell your broker to vote otherwise. Given what is being proposed cannot imagine anyone objecting to the resolutions. With all the major shareholders locked in for 18 months it means they are anticipating substantial gains, it also means an exceptionally small free float, more so as I think a lot of the PI's luck enough to have shares already will be keeping hold! This is so far removed from some of the trashy AIM shares you see around, very glad I am in on this, just hope I can get some more. Good to see the management team are going to be highly incentivised

Patience indeed. I am expecting this to be out of suspension around next month.. just show's no one should listen to the fraudsters over at shit prophets. the clues were all there as to where this was headed. The interview the CEO did had all the clues....

Key will be what they can achieve for licensing deals. Seems almost certain they will get multi million pounds for initial licensing, but the ongoing royalties can be worth even more. Added to that is the regional aspect, which can multiply that several times over. Intend going to the EGM, if management are there. Great thing about a company like this is it has global multi $b dollar potential, very low overhead (albeit clinical trials etc. can be very very expensive), and protected IP. The example given in the prospectus of Anacor and it's sale to Pfizer for $5.2B, is likely no exaggeration of the potential here. Nuformix team is top tier including their Chief scientific Advisor who is world renowned and is in Medicine Maker’s "Top 100 Most Influential Medicine Maker Power List” in April 2015" http://www.nuformix.com/about-nuformix/advisory-board/ As I said before, not often as PI's we could hope to get a bite at a company like this on the ground floor. Lets see what the early licensing (within weeks/months of listing, as per prospectus) brings, it could bag several times on that alone. Will be trying to get as much as I can on listing

Pre suspension prices are a steal!! It was very very difficult to get many and price was rising fast before suspension. I didn't get as many as I would have liked, however I have 75-100k ready to sink into this ASAP, might be difficult getting that though with such a small free float. With early licensing deals and further patents and IP in the pipeline this could be a fantastic earner over short, medium and long terms, with an eventual buyout in a couple to a few years. Cannot find a flaw in it at all. Not a fly by night AIM company, this is proper main market listing, world class scientists, and above all it could be transformative for some medical conditions.

Pharma is big business.. Not often an opportunity like this comes up, most companies like this, with world class scientists, stay private they then get bought out by the big companies. PI's don't often get a bite, not that there is much on the table here with such a small free float!

They currently have 14 patents Expecting to do deals on these patents soon after listing, further patents and pipeline of further pharmaceuticals/therapeutic applications Intention longer term is to exit with a sale to a large Pharma. Analogous example given in prospectus is a sale of Anacor to Pfizer for $5.2B Major shareholders voluntarily locking in for 18 months Extremely small free float of share likely less than 10% of enlarged shares World class scientists part of the team 10p should just be the start

EGM on the 13th October and tradable on 16th. Extremely small free float, and of that I would expect most will hold, could be less than 10% of the enlarged shareholding actually tradable That means it should rise pretty quickly indeed I will be holding mine, indeed trying to get more!! Was almost impossible to buy any quantity before suspension, could be just as difficult after... Prospectus say's they expect early deals to be done on their IP, that could be multi £m income fairly quickly

Great to get in on the ground floor of something like this that could have a huge impact on people's lives, and our wallets.

Link to prospectus: http://levrett.com/wp-content/uploads/Levrett-Prospectus-Clean_final.pdf

From the prospectus "the Directors and Directors on Admission believe that creation of a broader portfolio may position the Enlarged Group for a trade sale to a larger pharmaceutical company, such as Pfizer’s recent acquisition of Anacor Therapeutics, following their creation of a portfolio of boron-based pharmaceutical assets, albeit at a later stage of pharmaceutical development to the Enlarged Group’s products." Anacor was sold to Pfizzer for $5.2B As I said, this could be very very big

with the majority of shares being closely held (not tradable) that means a small free float. Another company Spreadex were involved with (RLH) trebled in value after coming out of suspension

"Following Re-Admission of the Enlarged Group, the Company, intends to demonstrate NXP001's potential for bioequivalence in humans within months of Re-Admission" Looks like they plan on adding value very quickly, could see licensing deals come thick and fast See Spreadex are also involved, and major shareholders are voluntarily locking themselves in for 18 months This feels like it could be very very very big!

14 patents, early licensing, this could be massive World class scientific team